Prenatal and new-born genetic testing Market Size, Share, Growth Report 2030

Prenatal and new-born genetic testing Market

Prenatal and new-born genetic testing Market - By Technology (Screening and Diagnostic), By End-Use (Hospitals, Maternity & Specialty Clinics, and Diagnostic Units), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Category: Biotechnology Report Format : PDF Pages: 125 Report Code: ZMR-6563 Published Date: Aug-2021 Status : Published

                                                                                                                                             

Market Size in 2020 Market Forecast in 2028 CAGR (in %) Base Year
USD 4.7 Billion USD 10.11 Billion 11.8% 2020

Prenatal and new-born genetic testing Market

Prenatal and new-born genetic testing Market: Industry Perspective

The global Prenatal and new-born genetic testing market size was worth around USD 4.7 Billion in 2020 and is predicted to grow to around USD 10.11 Billion by 2028 with a compound annual growth rate (CAGR) of roughly 11.8% between 2021 to 2028. The report offers an assessment and analysis of the Prenatal and newborn genetic testing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Global Prenatal and new-born genetic testing Market SizeRequest Free Sample

Prenatal and New-born Genetic Testing Market: Overview

Prenatal testing is referred to as medical tests performed during pregnancy to determine genetic disorders as well as birth defects in the fetus. Generally, these tests are carried out for detecting Tay-Sachs disease, sickle cell anemia, cystic fibrosis, and Down’s syndrome. Screening is continued post-baby birth and this testing is named newborn genetic testing. It is performed for determining genetically inherited disorders and phenylketonuria, critical congenital heart ailment, hearing loss, and muscular spinal atrophy. Prenatal and newborn genetic screening helps in reducing infant mortalities and enhances patient health by enabling effective diagnosis & treatment.

Prenatal and New-born Genetic Testing Market: Growth Drivers

Technological breakthroughs in healthcare & growing awareness about the advantages of prenatal & newborn genetic testing activities will steer prenatal and newborn genetic testing market growth. The surge in chromosomal disorders and the occurrence of hereditary diseases will propel business growth. In addition to this, a prominent rise in acceptance of non-invasive prenatal testing activities will scale up the expansion of the prenatal and newborn genetic testing industry size during the forecast timeline. The growing occurrence of genetic disorders in infants has translated into the need for prenatal and newborn genetic testing activities, thereby driving prenatal and newborn genetic testing market trends. However, ethical issues pertaining to prenatal & newborn genetic testing and cultural barriers can impede the growth of the prenatal and newborn genetic testing industry growth over the years ahead.

Prenatal and New-born Genetic Testing Market: Report Scope

Report Attributes Report Details
Report Name Prenatal and New-born Genetic Testing Market Research Report
Market Size in 2020 USD 4.7 Billion
Market Forecast in 2028 USD 10.11 Billion
Growth Rate CAGR of 11.8%
Number of Pages 214
Key Companies Covered Natera, Ariosa Diagnostics (Roche), Trivitron Healthcare, Sequenom, Berry Genomics, Qiagen, BGI, Biorad, Illumina, Laboratory Corporation of America, Verinata Health
Segments Covered By Technology, By End-Use, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2020
Historical Year 2016 to 2020
Forecast Year 2021 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Prenatal and new-born genetic testing Market: Regional Landscape

North America To Maintain Market Dominance During Forecast Timespan

The regional market dominance of North America over 2021-2028 can be due to supportive government healthcare policies along with the easy availability of new bio-techniques including real-time PCR and multiplex PCR systems. Apart from this, the rise in cases of genetic diseases in infants and demand for minimally invasive genetic screening in countries such as the U.S. will create lucrative growth avenues for the prenatal and newborn genetic testing market in North America over the forecast period. The surge in pregnancies in women after 35 years has posed a risk of a child being born with anomalies and this has prompted the need for prenatal and newborn genetic testing activities, thereby promulgating growth in the size of the prenatal and newborn genetic testing market in the North American sub-continent.

Prenatal and new-born genetic testing Market: Competitive Landscape

Key participants profiled in the report and influencing market growth are

  • Natera
  • Ariosa Diagnostics (Roche)
  • Trivitron Healthcare
  • Sequenom
  • Berry Genomics
  • Qiagen
  • BGI
  • Biorad
  • Illumina
  • Laboratory Corporation of America
  • Verinata Health

The global Prenatal and new-born genetic testing Market is segmented as follows:

By Technology

  • Screening
  • Diagnostic

By End-Use

  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Units

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Technological breakthroughs in healthcare & growing awareness about advantages of prenatal & new-born genetic testing activities will steer prenatal and new-born genetic testing market growth. Surge in chromosomal disorders and occurrence of hereditary diseases will propel business growth. In addition to this, a prominent rise in acceptance of non-invasive prenatal testing activities will scale up expansion of prenatal and new-born genetic testing industry size during forecast timeline. Growing occurrence of genetic disorders in infants has translated into need for prenatal and new-born genetic testing activities, thereby driving prenatal and new-born genetic testing market trends.

According to Zion market research report, the global Prenatal and new-born genetic testing market accrued earnings worth approximately 4.7(USD Billion) in 2020 and is predicted to gain revenue of about 10.11(USD Billion) by 2028, is set to record a CAGR of nearly 11.8% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to supportive government healthcare policies along with easy availability of new bio-techniques including real-time PCR and multiplex PCR systems. Apart from this, rise in cases of genetic diseases in infants and demand for minimally invasive genetic screening in countries such as the U.S. will create lucrative growth avenues for prenatal and new-born genetic testing market in North America over forecast period. Surge in pregnancies in women after 35 years has posed a risk of child being born with anomalies and this has prompted need for prenatal and new-born genetic testing activities, thereby promulgating growth in size of prenatal and new-born genetic testing market in North American sub-continent.     

 

The key market participants include Natera, Ariosa Diagnostics (Roche), Trivitron Healthcare, Sequenom, Berry Genomics, Qiagen, BGI, Biorad, Illumina, Laboratory Corporation of America, and Verinata Health.

 

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed